{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:36:18Z","timestamp":1790206578760,"version":"4.1.0"},"reference-count":42,"publisher":"Pleiades Publishing Ltd","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1134\/s0006297924604039","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T10:24:50Z","timestamp":1744971890000},"page":"276-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular Biomarkers of Neurodegeneration in Amyotrophic Lateral Sclerosis"],"prefix":"10.1134","volume":"90","author":[{"given":"Denis V.","family":"Shevchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir I.","family":"Tukhvatulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina S.","family":"Dzharullaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Berdalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria N.","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"2832_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O. Hardiman","year":"2017","unstructured":"Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., and van den Berg, L. H. (2017) Amyotrophic lateral sclerosis, Nat. Rev. Dis. Primers, 3, 17071, \nhttps:\/\/doi.org\/10.1038\/nrdp.2017.71.","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2832_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12408","volume":"7","author":"K. C. Arthur","year":"2016","unstructured":"Arthur, K. C., Calvo, A., Price, T. R., Geiger, J. T., Chi\u00f2, A., and Traynor, B. J. (2016) Projected increase in amyotrophic lateral sclerosis from 2015 to 2040, Nat. Commun., 7, 12408, \nhttps:\/\/doi.org\/10.1038\/ncomms12408.","journal-title":"Nat. Commun."},{"key":"2832_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1134\/S1819712422030114","volume":"16","author":"D. V. Shevchuk","year":"2022","unstructured":"Shevchuk, D. V., Abramova, A. A., and Zakharova, M. N. (2022) The role of inflammasomes in the pathogenesis of neurodegenerative diseases, Neurochem.\u00a0J., 16, 271-282, \nhttps:\/\/doi.org\/10.1134\/S1819712422030114.","journal-title":"Neurochem.\u00a0J."},{"key":"2832_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/21678421.2015.1049183","volume":"16","author":"A. Ludolph","year":"2015","unstructured":"Ludolph, A., Drory, V., Hardiman, O., Nakano, I., Ravits, J., Robberecht, W., and Shefner, J. (2015) A\u00a0revision of the El\u00a0Escorial criteria\u00a0\u2013 2015, Amyotroph. Lateral Scler. Frontotemporal. Degener., 16, 291-292, \nhttps:\/\/doi.org\/10.3109\/21678421.2015.1049183.","journal-title":"Amyotroph. Lateral Scler. Frontotemporal. Degener."},{"key":"2832_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01126","volume":"9","author":"D. Lanznaster","year":"2018","unstructured":"Lanznaster, D., de Assis, D. R., Corcia, P., Pradat, P.-F., and Blasco, H. (2018) Metabolomics biomarkers: a strategy toward therapeutics improvement in\u00a0ALS, Front. Neurol., 9, 1126, \nhttps:\/\/doi.org\/10.3389\/fneur.2018.01126.","journal-title":"Front. Neurol."},{"key":"2832_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01167","volume":"9","author":"K. Poesen","year":"2019","unstructured":"Poesen, K., and Van Damme, P. (2019) Diagnostic and prognostic performance of neurofilaments in ALS, Front. Neurol., 9, 1167, \nhttps:\/\/doi.org\/10.3389\/fneur.2018.01167.","journal-title":"Front. Neurol."},{"key":"2832_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.neurobiolaging.2014.10.019","volume":"36","author":"C. Wilke","year":"2015","unstructured":"Wilke, C., Deuschle, C., Rattay, T. W., Maetzler, W., and Synofzik, M. (2015) Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis, Neurobiol. Aging, 36, 1072-1074, \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.019.","journal-title":"Neurobiol. Aging"},{"key":"2832_CR8","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","volume":"388","author":"J. R. Burrell","year":"2016","unstructured":"Burrell, J. R., Halliday, G. M., Kril, J. J., Ittner, L. M., G\u00f6tz, J., Kiernan, M. C., and Hodges, J. R. (2016) The\u00a0frontotemporal dementia-motor neuron disease continuum, Lancet, 388, 919-931, \nhttps:\/\/doi.org\/10.1016\/S0140-6736(16)00737-6.","journal-title":"Lancet"},{"key":"2832_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00702-009-0271-4","volume":"116","author":"P. Steinacker","year":"2009","unstructured":"Steinacker, P., Hendrich, C., Sperfeld, A.-D., Jesse, S., Lehnert, S., Pabst, A., von Arnim, C. A. F., Mottaghy, F. M., Uttner, I., Tumani, H., Ludolph, A., and Otto, M. (2009) Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration, J.\u00a0Neural. Transm., 116, 1169-1178, \nhttps:\/\/doi.org\/10.1007\/s00702-009-0271-4.","journal-title":"J.\u00a0Neural. Transm."},{"key":"2832_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1468-1331.2009.02717.x","volume":"17","author":"R. Rusina","year":"2010","unstructured":"Rusina, R., Ridzo\u0148, P., Kuli\u0161t\u2019\u00e1k, P., Keller, O., Barto\u0161, A., Buncov\u00e1, M., Fialov\u00e1, L., Koukol\u00edk, F., and Mat\u011bj, R. (2010) Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study, Eur.\u00a0J. Neurol., 17, 23-30, \nhttps:\/\/doi.org\/10.1111\/j.1468-1331.2009.02717.x.","journal-title":"Eur.\u00a0J. Neurol."},{"key":"2832_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","volume":"9","author":"J. Hardy","year":"2006","unstructured":"Hardy, J. (2006) Alzheimer\u2019s disease: the amyloid cascade hypothesis: an update and reappraisal, J.\u00a0Alzheimer\u2019s Dis., 9, 151-153, \nhttps:\/\/doi.org\/10.3233\/JAD-2006-9S317.","journal-title":"J.\u00a0Alzheimer\u2019s Dis."},{"key":"2832_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082911","volume":"21","author":"D. Lanznaster","year":"2020","unstructured":"Lanznaster, D., Hergesheimer, R. C., Bakkouche, S. E., Beltran, S., Vourc\u2019h, P., Andres, C. R., Dufour-Rainfray, D., Corcia, P., and Blasco, H. (2020) A\u03b21-42 and tau as potential biomarkers for diagnosis and prognosis of amyotrophic lateral sclerosis, Int.\u00a0J. Mol. Sci., 21, 2911, \nhttps:\/\/doi.org\/10.3390\/ijms21082911.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2832_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F. Kimura","year":"2006","unstructured":"Kimura, F., Fujimura, C., Ishida, S., Nakajima, H., Furutama, D., Uehara, H., Shinoda, K., Sugino, M., and Hanafusa, T. (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS, Neurology, 66, 265-267, \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000194316.91908.8a.","journal-title":"Neurology"},{"key":"2832_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.14283\/jpad.2023.43","volume":"10","author":"L. Iaccarino","year":"2023","unstructured":"Iaccarino, L., Burnham, S. C., Dell\u2019Agnello, G., Dowsett, S. A., and Epelbaum, S. (2023) Diagnostic biomarkers of amyloid and tau pathology in Alzheimer\u2019s disease: an overview of tests for clinical practice in the United States and Europe, J.\u00a0Prev. Alzheimers Dis., 10, 426-442, \nhttps:\/\/doi.org\/10.14283\/jpad.2023.43.","journal-title":"J.\u00a0Prev. Alzheimers Dis."},{"key":"2832_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3233\/JAD-180409","volume":"66","author":"S. Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh, S., Mometto, N., Bartoletti-Stella, A., Polischi, B., Oppi, F., Poda, R., Stanzani Maserati, M., Cortelli, P., Liguori, R., Capellari, S., and Parchi, P. (2018) Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: a single-center study, J.\u00a0Alzheimer\u2019s Dis., 66, 551-563, \nhttps:\/\/doi.org\/10.3233\/JAD-180409.","journal-title":"J.\u00a0Alzheimer\u2019s Dis."},{"key":"2832_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0361-3","volume":"10","author":"R. W. Paterson","year":"2018","unstructured":"Paterson, R. W., Slattery, C. F., Poole, T., Nicholas, J. M., Magdalinou, N. K., Toombs, J., Chapman, M. D., Lunn, M. P., Heslegrave, A. J., Foiani, M. S., Weston, P. S. J., Keshavan, A., Rohrer, J. D., Rossor, M. N., Warren, J. D., Mummery, C. J., Blennow, K., Fox, N. C., Zetterberg, H., and Schott, J. M. (2018) Cerebrospinal fluid in the differential diagnosis of Alzheimer\u2019s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic, Alzheimers Res. Ther., 10, 32, \nhttps:\/\/doi.org\/10.1186\/s13195-018-0361-3.","journal-title":"Alzheimers Res. Ther."},{"key":"2832_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116756","volume":"412","author":"L.-Q. Ye","year":"2020","unstructured":"Ye, L.-Q., Li, X.-Y., Zhang, Y.-B., Cheng, H.-R., Ma, Y., Chen, D.-F., Tao, Q.-Q., Li, H.-L., and Wu, Z.-Y. (2020) The\u00a0discriminative capacity of CSF \u03b2-amyloid\u00a042 and Tau in neurodegenerative diseases in the Chinese population, J.\u00a0Neurol. Sci., 412, 116756, \nhttps:\/\/doi.org\/10.1016\/j.jns.2020.116756.","journal-title":"J.\u00a0Neurol. Sci."},{"key":"2832_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00636-z","volume":"12","author":"C. Hadjichrysanthou","year":"2020","unstructured":"Hadjichrysanthou, C., Evans, S., Bajaj, S., Siakallis, L. C., McRae-McKee, K., de Wolf, F., and Anderson, R. M. (2020) The\u00a0dynamics of biomarkers across the clinical spectrum of Alzheimer\u2019s disease, Alzheimers Res. Ther., 12, 74, \nhttps:\/\/doi.org\/10.1186\/s13195-020-00636-z.","journal-title":"Alzheimers Res. Ther."},{"key":"2832_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00384","volume":"9","author":"S. Stanga","year":"2018","unstructured":"Stanga, S., Brambilla, L., Tasiaux, B., Dang, A. H., Ivanoiu, A., Octave, J.-N., Rossi, D., van Pesch, V., and Kienlen-Campard, P. (2018) A\u00a0role for GDNF and Soluble APP as biomarkers of amyotrophic lateral sclerosis pathophysiology, Front. Neurol., 9, 384, \nhttps:\/\/doi.org\/10.3389\/fneur.2018.00384.","journal-title":"Front. Neurol."},{"key":"2832_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.brainres.2011.02.052","volume":"1386","author":"A. M. Herman","year":"2011","unstructured":"Herman, A. M., Khandelwal, P. J., Stanczyk, B. B., Rebeck, G. W., and Moussa, C. E.-H. (2011) \u03b2-Amyloid triggers ALS-associated TDP-43 pathology in AD\u00a0models, Brain Res., 1386, 191-199, \nhttps:\/\/doi.org\/10.1016\/j.brainres.2011.02.052.","journal-title":"Brain Res."},{"key":"2832_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.nbd.2005.01.012","volume":"19","author":"N. Y. Calingasan","year":"2005","unstructured":"Calingasan, N. Y., Chen, J., Kiaei, M., and Beal, M. F. (2005) \u03b2-amyloid\u00a042 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients, Neurobiol. Dis., 19, 340-347, \nhttps:\/\/doi.org\/10.1016\/j.nbd.2005.01.012.","journal-title":"Neurobiol. Dis."},{"key":"2832_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000048642","volume":"13","author":"M. Sj\u00f6gren","year":"2002","unstructured":"Sj\u00f6gren, M., Davidsson, P., Wallin, A., Gran\u00e9rus, A.-K., Grundstr\u00f6m, E., Askmark, H., Vanmechelen, E., and Blennow, K. (2002) Decreased CSF-\u03b2-amyloid\u00a042 in Alzheimer\u2019s disease and amyotrophic lateral sclerosis may reflect mismetabolism of \u03b2-amyloid induced by disparate mechanisms, Dement. Geriatr. Cogn. Disord., 13, 112-118, \nhttps:\/\/doi.org\/10.1159\/000048642.","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"2832_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s004010051015","volume":"97","author":"S. Sasaki","year":"1999","unstructured":"Sasaki, S., and Iwata, M. (1999) Immunoreactivity of \u03b2-amyloid precursor protein in amyotrophic lateral sclerosis, Acta Neuropathol., 97, 463-468, \nhttps:\/\/doi.org\/10.1007\/s004010051015.","journal-title":"Acta Neuropathol."},{"key":"2832_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C. Ballatore","year":"2007","unstructured":"Ballatore, C., Lee, V. M.-Y., and Trojanowski, J. Q. (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders, Nat. Rev. Neurosci., 8, 663-672, \nhttps:\/\/doi.org\/10.1038\/nrn2194.","journal-title":"Nat. Rev. Neurosci."},{"key":"2832_CR25","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/ene.14789","volume":"28","author":"L. Agnello","year":"2021","unstructured":"Agnello, L., Colletti, T., Lo Sasso, B., Vidali, M., Spataro, R., Gambino, C. M., Giglio, R. V., Piccoli, T., Bivona, G., La Bella, V., and Ciaccio, M. (2021) Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis, Eur.\u00a0J. Neurol., 28, 1868-1875, \nhttps:\/\/doi.org\/10.1111\/ene.14789.","journal-title":"Eur.\u00a0J. Neurol."},{"key":"2832_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2015.02.017","volume":"77","author":"B. J. Murdock","year":"2015","unstructured":"Murdock, B. J., Bender, D. E., Segal, B. M., and Feldman, E. L. (2015) The\u00a0dual roles of immunity in\u00a0ALS: injury overrides protection, Neurobiol. Dis., 77, 1-12, \nhttps:\/\/doi.org\/10.1016\/j.nbd.2015.02.017.","journal-title":"Neurobiol. Dis."},{"key":"2832_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1212\/WNL.0b013e318249f776","volume":"78","author":"O. Kano","year":"2012","unstructured":"Kano, O., Beers, D. R., Henkel, J. S., and Appel, S. H. (2012) Peripheral nerve inflammation in ALS mice: cause or consequence, Neurology, 78, 833-835, \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e318249f776.","journal-title":"Neurology"},{"key":"2832_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-020-00933-3","volume":"18","author":"J. B. Delaye","year":"2021","unstructured":"Delaye, J. B., Lanznaster, D., Veyrat-Durebex, C., Fontaine, A., Bacle, G., Lefevre, A., Hergesheimer, R., Lecron, J. C., Vourc\u2019h, P., Andres, C. R., Maillot, F., Corcia, P., Emond, P., and Blasco, H. (2021) Behavioral, hormonal, inflammatory, and metabolic effects associated with FGF21-pathway activation in an ALS mouse model, Neurotherapeutics, 18, 297-308, \nhttps:\/\/doi.org\/10.1007\/s13311-020-00933-3.","journal-title":"Neurotherapeutics"},{"key":"2832_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","volume":"7","author":"P. M. Andersen","year":"2011","unstructured":"Andersen, P. M., and Al-Chalabi, A. (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat. Rev. Neurol., 7, 603-615, \nhttps:\/\/doi.org\/10.1038\/nrneurol.2011.150.","journal-title":"Nat. Rev. Neurol."},{"key":"2832_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042272","volume":"5","author":"I. Hasantari","year":"2024","unstructured":"Hasantari, I., Nicolas, N., Alzieu, P., Leval, L., Shalabi, A., Grolleau, S., and Dinet, V. (2024) Factor\u00a0H\u2019s control of complement activation emerges as a significant and promising therapeutic target for Alzheimer\u2019s disease treatment, Int.\u00a0J. Mol. Sci., 5, 2272, \nhttps:\/\/doi.org\/10.3390\/ijms25042272.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2832_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50420-9","volume":"9","author":"C. Borras","year":"2019","unstructured":"Borras, C., Canonica, J., Jorieux, S., Abache, T., El Sanharawi, M., Klein, C., Delaunay, K., Jonet, L., Salvodelli, M., Naud, M.-C., Arsenijevic, Y., Shalabi, A., Souchaud, L., Behar-Cohen, F., and Dinet, V. (2019) CFH exerts anti-oxidant effects on retinal pigment epithelial cells independently from protecting against membrane attack complex, Sci. Rep., 9, 13873, \nhttps:\/\/doi.org\/10.1038\/s41598-019-50420-9.","journal-title":"Sci. Rep."},{"key":"2832_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00443","volume":"11","author":"C. Borras","year":"2020","unstructured":"Borras, C., Delaunay, K., Slaoui, Y., Abache, T., Jorieux, S., Naud, M.-C., Sanharawi, M. E., Gelize, E., Lassiaz, P., An, N., Kowalczuk, L., Ayassami, C., Moulin, A., Behar-Cohen, F., Mascarelli, F., and Dinet, V. (2020) Mechanisms of FH protection against neovascular AMD, Front. Immunol., 11, 443, \nhttps:\/\/doi.org\/10.3389\/fimmu.2020.00443.","journal-title":"Front. Immunol."},{"key":"2832_CR33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000203916","volume":"100","author":"Y. Li","year":"2023","unstructured":"Li, Y., Smith, V., Skinner, S., Robertson, A., Lenkiu, L., Cannon-Patron, H., Martinez, D., Hanson, H., Hickman, J. J., and Eyerman, D. (2023) Effect of complement\u00a0C3 inhibition with pegcetacoplan in an iPSC-derived ALS neuromuscular junction model of neuroinflammation (P13-4.004), Neurology, 100, 4341, \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000203916.","journal-title":"Neurology"},{"key":"2832_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01596-4","volume":"29","author":"K. Kl\u00ed\u010dov\u00e1","year":"2024","unstructured":"Kl\u00ed\u010dov\u00e1, K., Mare\u0161, J., Men\u0161\u00edkov\u00e1, K., Kaiserov\u00e1, M., Friedeck\u00fd, D., Ka\u0148ovsk\u00fd, P., Strnad, M., and Mat\u011bj, R. (2024) Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis, Eur.\u00a0J. Med. Res., 29, 31, \nhttps:\/\/doi.org\/10.1186\/s40001-023-01596-4.","journal-title":"Eur.\u00a0J. Med. Res."},{"key":"2832_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/nan.12575","volume":"46","author":"J. M. Gregory","year":"2020","unstructured":"Gregory, J. M., Elliott, E., McDade, K., Bak, T., Pal, S., Chandran, S., Abrahams, S., and Smith, C. (2020) Neuronal clusterin expression is associated with cognitive protection in amyotrophic lateral sclerosis, Neuropathol. Appl. Neurobiol., 46, 255-263, \nhttps:\/\/doi.org\/10.1111\/nan.12575.","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"2832_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.4560","volume":"71","author":"R. S. Desikan","year":"2014","unstructured":"Desikan, R. S., Thompson, W. K., Holland, D., Hess, C. P., Brewer, J. B., Zetterberg, H., Blennow, K., Andreassen, O. A., McEvoy, L. K., Hyman, B. T., and Dale, A. M. (2014) The\u00a0role of clusterin in amyloid-\u03b2-associated neurodegeneration, JAMA Neurol., 71, 180, \nhttps:\/\/doi.org\/10.1001\/jamaneurol.2013.4560.","journal-title":"JAMA Neurol."},{"key":"2832_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00268","volume":"12","author":"K. Chaplot","year":"2020","unstructured":"Chaplot, K., Jarvela, T. S., and Lindberg, I. (2020) Secreted chaperones in neurodegeneration, Front. Aging Neurosci., 12, 268, \nhttps:\/\/doi.org\/10.3389\/fnagi.2020.00268.","journal-title":"Front. Aging Neurosci."},{"key":"2832_CR38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s12192-013-0427-x","volume":"18","author":"S. Zinkie","year":"2013","unstructured":"Zinkie, S., Gentil, B. J., Minotti, S., and Durham, H. D. (2013) Expression of the protein chaperone, clusterin, in spinal cord cells constitutively and following cellular stress, and upregulation by treatment with Hsp90 inhibitor, Cell Stress Chaperones, 18, 745-758, \nhttps:\/\/doi.org\/10.1007\/s12192-013-0427-x.","journal-title":"Cell Stress Chaperones"},{"key":"2832_CR39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1600-0854.2007.00549.x","volume":"8","author":"P. Nizard","year":"2007","unstructured":"Nizard, P., Tetley, S., Le Dr\u00e9an, Y., Watrin, T., Goff, P. L., Wilson, M. R., and Michel, D. (2007) Stress-induced retrotranslocation of clusterin\/ApoJ into the cytosol, Traffic, 8, 554-565, \nhttps:\/\/doi.org\/10.1111\/j.1600-0854.2007.00549.x.","journal-title":"Traffic"},{"key":"2832_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0481-1","volume":"5","author":"J. M. Gregory","year":"2017","unstructured":"Gregory, J. M., Whiten, D. R., Brown, R., Barros, T. P., Kumita, J. R., Yerbury, J. J., Satapathy, S., McDade, K., Smith, C., Luheshi, L. M., Dobson, C. M., and Wilson, M. R. (2017) Clusterin protects neurons against intracellular proteotoxicity, Acta Neuropathol. Commun., 5, 81, \nhttps:\/\/doi.org\/10.1186\/s40478-017-0481-1.","journal-title":"Acta Neuropathol. Commun."},{"key":"2832_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jns.2015.12.023","volume":"361","author":"H. P\u0159ikrylov\u00e1 Vranov\u00e1","year":"2016","unstructured":"P\u0159ikrylov\u00e1 Vranov\u00e1, H., H\u00e9nykov\u00e1, E., Mare\u0161, J., Kaiserov\u00e1, M., Men\u0161\u00edkov\u00e1, K., Va\u0161t\u00edk, M., Hlu\u0161t\u00edk, P., Zapletalov\u00e1, J., Strnad, M., Stejskal, D., and Ka\u0148ovsk\u00fd, P. (2016) Clusterin CSF levels in differential diagnosis of neurodegenerative disorders, J.\u00a0Neurol. Sci., 361, 117-121, \nhttps:\/\/doi.org\/10.1016\/j.jns.2015.12.023.","journal-title":"J.\u00a0Neurol. Sci."},{"key":"2832_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/21678421.2018.1433689","volume":"19","author":"Z. Xu","year":"2018","unstructured":"Xu, Z., Lee, A., Nouwens, A., Henderson, R. D., and McCombe, P. A. (2018) Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects, Amyotroph. Lateral Scler. Frontotemporal Degener., 19, 362-376, \nhttps:\/\/doi.org\/10.1080\/21678421.2018.1433689.","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297924604039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297924604039","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297924604039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:22:41Z","timestamp":1773620561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297924604039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2832"],"URL":"https:\/\/doi.org\/10.1134\/s0006297924604039","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}